No Detail Found!

Cyberknife Radiosurgery in Hepatocellular Carcinoma

Author(s)
Bakhtawar Memon Department of Radiology and Cyberknife Robotic Radiosurgery, Jinnah Postgraduate Medical Centre,Karachi,Pakistan
Shazia Kadri Department of Radiology and Cyberknife Robotic Radiosurgery, Jinnah Postgraduate Medical Centre,Karachi,Pakistan
Nimrah Sultana Department of Radiology and Cyberknife Robotic Radiosurgery, Jinnah Postgraduate Medical Centre,Karachi,Pakistan
Kamran Saeed Department of Radiology and Cyberknife Robotic Radiosurgery, Jinnah Postgraduate Medical Centre,Karachi,Pakistan
Naveed Ahmed Department of Radiology and Cyberknife Robotic Radiosurgery, Jinnah Postgraduate Medical Centre,Karachi,Pakistan
Tariq Mahmood Department of Radiology and Cyberknife Robotic Radiosurgery, Jinnah Postgraduate Medical Centre,Karachi,Pakistan
Abstract
Objective: To determine the outcome of Stereotactic Body Radiation Therapy (SBRT) and its prognostic factors among hepatocellular carcinoma (HCC) patients. Study Design: Descriptive study. Place and Duration of Study: Department of Radiology and Cyberknife Robotic Radiosurgery, Jinnah Postgraduate Medical Centre (JPMC), Karachi, Pakistan from 1st July 2019 to 31st August 2020. Methodology: All patients of either gender age 18 years and above presenting with pathological con rmation of HCC, ECOG performance status of d 2 and child Pugh A or B were consecutively enrolled. Progression of >20% was de ned as progressive disease (PD). SBRT was performed using the Cyberknife. Clinical outcome was measured in terms of progression free survival. Moreover, radiation induced toxicity was also observed along with other predictor variables. Results: Of 52 patients, the median age was 58 (53-59) years. There were 42 (80.8%) males and 10 (19.2%) females. All patients were alive at 3 months, i.e. 52 (100%). However, at 6 months, 49 (94.2%) were alive, at 9 months, 38 (73.1%) patients were alive while at 1 year, 24 (46.2%) patients were alive. A signi cant association was observed for survival at 6 months and ECOG performance status score (p-value 0.036), survival at 9 months and AFP (p= 0.003), survival at 1 year and age (p = 0.019), survival at 1 year and HBV (p = 0.001), and survival at 1 year and previous treatment (p = 0.010). Moreover, none of the patients reported complications / radiation induced liver toxicity. Conclusion: A higher e ciency of SBRT was found among HCC patients attending Radiology Department.
Publication Details
Page(s) 532-536
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 31, Issue: 5, Year: 2021

Request the full text from PASTIC

Keywords
toxicity, Hepatocellular carcinoma, survival, Stereotactic body radiation therapy
0

Citations

0

Downloads

94

Views